OTCPK:CLYX.F

Stock Analysis Report

Executive Summary

Calyx Ventures Inc. engages in the development of custom software for enterprises and start-up companies in Canada.


Snowflake Analysis

Slightly overvalued with imperfect balance sheet.

Share Price & News

How has Calyx Ventures's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CLYX.F's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-0.4%

CLYX.F

0.2%

US Software

0.9%

US Market


1 Year Return

-70.4%

CLYX.F

42.1%

US Software

20.0%

US Market

Return vs Industry: CLYX.F underperformed the US Software industry which returned 42.3% over the past year.

Return vs Market: CLYX.F underperformed the US Market which returned 20.1% over the past year.


Shareholder returns

CLYX.FIndustryMarket
7 Day-0.4%0.2%0.9%
30 Day-21.8%7.7%1.4%
90 Dayn/a17.8%8.8%
1 Year-70.4%-70.4%43.7%42.1%22.5%20.0%
3 Year-89.3%-89.3%152.0%141.7%49.9%40.3%
5 Year-41.3%-41.3%224.3%201.1%73.2%54.1%

Price Volatility Vs. Market

How volatile is Calyx Ventures's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Calyx Ventures undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CLYX.F ($0.01) is trading below our estimate of fair value ($0.11)

Significantly Below Fair Value: CLYX.F is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CLYX.F is unprofitable, so we can't compare its PE Ratio to the Software industry average.

PE vs Market: CLYX.F is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CLYX.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CLYX.F has negative assets, so we can't compare its PB Ratio to the US Software industry average.


Next Steps

Future Growth

How is Calyx Ventures forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.4%

Forecasted Software industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Calyx Ventures has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of CLYX.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Calyx Ventures's filings and announcements here.
  • Explore growth companies in the Software industry.

Past Performance

How has Calyx Ventures performed over the past 5 years?

-31.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CLYX.F is currently unprofitable.

Growing Profit Margin: CLYX.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CLYX.F is unprofitable, and losses have increased over the past 5 years at a rate of -31.4% per year.

Accelerating Growth: Unable to compare CLYX.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CLYX.F is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (17.1%).


Return on Equity

High ROE: CLYX.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Calyx Ventures's financial position?


Financial Position Analysis

Short Term Liabilities: CLYX.F has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: CLYX.F has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: CLYX.F has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: CLYX.F's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Inventory Level: CLYX.F has a high level of physical assets or inventory.

Debt Coverage by Assets: CLYX.F has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable CLYX.F has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: CLYX.F is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 3.7% per year.


Next Steps

Dividend

What is Calyx Ventures's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate CLYX.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate CLYX.F's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CLYX.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CLYX.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CLYX.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.7yrs

Average management tenure


CEO

Roger Forde 0

4.7yrs

Tenure

CA$213,000

Compensation

Mr. Roger Henderson Forde has been Chief Executive Officer, President and Director of Calyx Bio-Ventures Inc. since June 12, 2015. Mr. Forde is also the founder of Cannigistics Agri-Solutions Corp. He has  ...


CEO Compensation Analysis

Compensation vs Market: Roger's total compensation ($USD160.73K) is below average for companies of similar size in the US market ($USD521.92K).

Compensation vs Earnings: Roger's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Roger Forde
President4.7yrsCA$213.00k8.19% CA$87.9k
Gavin McMillan
CFO & Director4.7yrsCA$9.00kno data
Tom Mamic
Chief Executive Officer of Agrisoma Biosciences Inc and President of Agrisoma Biosciences Inc15.8yrsCA$168.75kno data

4.7yrs

Average Tenure

Experienced Management: CLYX.F's management team is considered experienced (4.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Roger Forde
President4.7yrsCA$213.00k8.19% CA$87.9k
Gavin McMillan
CFO & Director4.7yrsCA$9.00kno data
Graeme Watson
Independent Director5yrsno data0.21% CA$2.3k
Jack Antel
Member of MS Advisory Board0yrsno datano data
Leslie Weiner
Member of MS Advisory Board0yrsno datano data
Joel Oger
Member of MS Advisory Board0yrsno datano data
Lorne Kastrukoff
Member of MS Advisory Board0yrsno datano data
Dennis Bourdette
Member of MS Advisory Board0yrsno datano data
Adrian Bak
Independent Director5.2yrsno data0.69% CA$7.4k
James Bowen
Member of MS Advisory Board0yrsno datano data

4.8yrs

Average Tenure

Experienced Board: CLYX.F's board of directors are considered experienced (4.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.3%.


Top Shareholders

Company Information

Calyx Ventures Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Calyx Ventures Inc.
  • Ticker: CLYX.F
  • Exchange: OTCPK
  • Founded: 2008
  • Industry: Application Software
  • Sector: Software
  • Market Cap: CA$1.422m
  • Listing Market Cap: CA$1.073m
  • Shares outstanding: 94.78m
  • Website: https://www.calyxbio.com

Location

  • Calyx Ventures Inc.
  • 1590–1111 West Georgia Street
  • Vancouver
  • British Columbia
  • V6E 4M3
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CYXTSXV (TSX Venture Exchange)YesCommon SharesCACADSep 2008
3CXDB (Deutsche Boerse AG)YesCommon SharesDEEURSep 2008
CLYX.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDSep 2008

Biography

Calyx Ventures Inc. engages in the development of custom software for enterprises and start-up companies in Canada. The company provides software solutions to the indoor agriculture; and owns a portfolio of proprietary intellectual property with applications in crop enhancement. It also offers online access to information and products for the legal cannabis and hemp industries; and messaging software platforms. The company was formerly known as Calyx Bio-Ventures Inc. and changed its name to Calyx Ventures Inc. in February 2018. Calyx Ventures Inc. was incorporated in 2008 and is headquartered in Vancouver, Canada. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/18 00:54
End of Day Share Price2020/02/13 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.